Photo from V. Lokesh Battula/LinkedIn
Dec 1, 2023, 19:13
V. Lokesh Battula: Our findings on resistance to Fluorothymidine 3 inhibitors in Acute Myeloid Leukemia are now published in the Leukemia Journal
V. Lokesh Battula, Associate Professor at MD Anderson Cancer Center, shared on LinkedIn:
“Happy to report that our findings on resistance to FLT3 inhibitors in AML are now published in the Leukemia Journal. In this report, we have reported ACVR1 as a novel resistance factor for FLT3 inhibitors in AML and introduced a novel FLT3-ACVR1 dual inhibitor (TP-0184) as a single agent to target both FLT3 and its resistance factor in AML!”
Read the article here.
Source: V. Lokesh Battula/LinkedIn
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Nov 19, 2024, 09:53
Nov 19, 2024, 09:44
Nov 19, 2024, 09:40
Nov 19, 2024, 09:28
Nov 19, 2024, 09:16
Nov 19, 2024, 02:34